CPA1 and infection: Though the CpA-Dcr2-L1 (line #1) has shown slightly greater resistance to DENV2, as measured by infection prevalence (S1 Fig), the CpA-Dcr2-L2 (line #2) showed significant resistance to both ZIKV and DENV2 viruses and was therefore used for down-stream studies.